BRUSSELS--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):
Regulated information1
“Our global momentum continued this quarter. The strength of our diversified footprint and consumer demand for our megabrands delivered another quarter of broad-based top- and bottom-line growth. EBITDA grew by double-digits and the continued optimization of our business drove a 25% increase in Underlying EPS. We are encouraged with our performance in the first half of the year and remain focused on consistent execution of our strategy.” – Michel Doukeris, CEO, AB InBev
Total Revenue + 2.7% Revenue increased by 2.7% in 2Q24 with revenue per hl growth of 3.6% and by 2.7% in HY24 with revenue per hl growth of 3.5%.
3.3% increase in combined revenues of our megabrands, led by Corona, which grew by 5.6% outside of its home market in 2Q24.
Approximately 70% of our revenue is through B2B digital platforms with the monthly active user base of BEES reaching 3.8 million users in 2Q24.
Approximately 140 million USD of revenue generated by our digital direct-to-consumer ecosystem in 2Q24.
Total Volume - 0.8% In 2Q24, total volumes declined by 0.8%, with own beer volumes down by 1.3% and non-beer volumes up by 3.4%. In HY24, total volumes declined by 0.7% with own beer volumes down by 1.3% and non-beer volumes up by 3.5%.
| Normalized EBITDA + 10.2% In 2Q24, normalized EBITDA increased by 10.2% to 5 302 million USD with a normalized EBITDA margin expansion of 236bps to 34.6%. In HY24, normalized EBITDA increased by 7.8% to 10 288 million USD with a normalized EBITDA margin expansion of 165bps to 34.4%.
Underlying Profit 1 811 million USD Underlying profit (profit attributable to equity holders of AB InBev excluding non-underlying items and the impact of hyperinflation) was 1 811 million USD in 2Q24 compared to 1 452 million USD in 2Q23 and was 3 320 million USD in HY24 compared to 2 762 million USD in HY23.
Underlying EPS 0.90 USD Underlying EPS was 0.90 USD in 2Q24, an increase from 0.72 USD in 2Q23 and was 1.66 USD in HY24, an increase from 1.37 USD in HY23.
|
Net Debt to EBITDA 3.42x Net debt to normalized EBITDA ratio was 3.42x at 30 June 2024 compared to 3.70x at 30 June 2023 and 3.38x at 31 December 2023. |
The 2024 Half Year Financial Report is available on our website at www.ab-inbev.com
1The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market. For important disclaimers and notes on the basis of preparation, please refer to page 16. |
Management comments
Consistent execution of our strategy delivered double-digit EBITDA growth with margin expansion of 236bps and a 25% increase in Underlying EPS
Top-line increased by 2.7%, with revenue growth in approximately 65% of our markets, driven by a revenue per hl increase of 3.6% as a result of revenue management initiatives. Volume growth in our Middle Americas, South America, Europe and Africa regions was primarily offset by performance in China and Argentina, resulting in an overall volume decline of 0.8%. EBITDA increased by 10.2% with production cost efficiencies and disciplined overhead management driving EBITDA margin expansion of 236bps. Underlying EPS was 0.90 USD, a 25% increase versus 2Q23, driven primarily by nominal EBITDA growth.
Progressing our strategic priorities
We continue to execute on and invest in three key strategic pillars to deliver consistent growth and long-term value creation.
(1) Lead and grow the category:
We delivered volume growth in 50% of our markets in 2Q24 and gained market share in the majority in HY24, according to our estimates.
(2) Digitize and monetize our ecosystem:
BEES captured 11.7 billion USD of gross merchandise value (GMV), a 20% increase versus 2Q23 with approximately 70% of our revenue through B2B digital channels. BEES Marketplace captured 530 million USD in GMV from sales of third-party products, a 55% increase versus 2Q23.
(3) Optimize our business:
We continue to make progress on deleveraging with net debt to EBITDA reaching 3.42x as of 30 June 2024 versus 3.70x as of 30 June 2023. In HY24, we invested 5.3 billion USD in capex and sales and marketing while delivering free cash flow of approximately 0.9 billion USD, a 1.4 billion USD improvement versus HY23.
(1) Lead and grow the category
We continued to invest in our megabrands, mega platforms and brand building capabilities this quarter. According to the Kantar BrandZ 2024 report, our portfolio now holds 8 of the top 10 most valuable beer brands in the world, with Corona and Budweiser #1 and #2 respectively. Our marketing effectiveness and creativity were recognized by again being named the most effective marketer in the world by both Effies and the World Advertising Research Center and being the most awarded beverage company at the 2024 Cannes Lions International Festival of Creativity. Our performance across each of our 5 category expansion levers was led by our megabrands which delivered continued volume growth and a 3.3% revenue increase in 2Q24.
(2) Digitize and monetize our ecosystem
(3) Optimize our business
Creating a future with more cheers
In the first half of this year, our business delivered EBITDA growth of 7.8% with margin expansion of 165bps, while we continued to invest for the long-term in our brands, facilities and digital initiatives. Our nominal EBITDA growth and the continued optimization of our business drove strong operating leverage, resulting in an Underlying EPS increase of 21% in HY24. Our performance is made possible by the dedication and hard work of our people and we take this opportunity to thank all our colleagues globally for their passion and commitment. The beer category is large and growing, and our unique global leadership advantages, replicable growth drivers and superior profitability position us well to deliver on our purpose to create a future with more cheers.
2024 Outlook
Figure 1. Consolidated performance (million USD) | ||||||
2Q23 | 2Q24 | Organic | ||||
growth | ||||||
Total Volumes (thousand hls) | 147 583 | 146 302 | -0.8% | |||
AB InBev own beer | 128 750 | 126 926 | -1.3% | |||
Non-beer volumes | 17 636 | 18 235 | 3.4% | |||
Third party products | 1 197 | 1 140 | -4.7% | |||
Revenue | 15 120 | 15 333 | 2.7% | |||
Gross profit | 8 101 | 8 567 | 7.0% | |||
Gross margin | 53.6% | 55.9% | 224bps | |||
Normalized EBITDA | 4 909 | 5 302 | 10.2% | |||
Normalized EBITDA margin | 32.5% | 34.6% | 236bps | |||
Normalized EBIT | 3 569 | 3 905 | 11.9% | |||
Normalized EBIT margin | 23.6% | 25.5% | 209bps | |||
| ||||||
Profit attributable to equity holders of AB InBev | 339 | 1 472 | ||||
Underlying profit attributable to equity holders of AB InBev | 1 452 | 1 811 | ||||
| ||||||
Earnings per share (USD) | 0.17 | 0.73 | ||||
Underlying earnings per share (USD) | 0.72 | 0.90 |
| |||
HY23 | HY24 | Organic | ||||
growth | ||||||
Total Volumes (thousand hls) | 288 131 | 285 837 | -0.7% | |||
AB InBev own beer | 249 810 | 246 313 | -1.3% | |||
Non-beer volumes | 36 223 | 37 465 | 3.5% | |||
Third party products | 2 098 | 2 059 | -1.8% | |||
Revenue | 29 333 | 29 880 | 2.7% | |||
Gross profit | 15 796 | 16 461 | 4.9% | |||
Gross margin | 53.9% | 55.1% | 117bps | |||
Normalized EBITDA | 9 668 | 10 288 | 7.8% | |||
Normalized EBITDA margin | 33.0% | 34.4% | 165bps | |||
Normalized EBIT | 7 072 | 7 547 | 8.5% | |||
Normalized EBIT margin | 24.1% | 25.3% | 135bps | |||
| ||||||
Profit attributable to equity holders of AB InBev | 1 977 | 2 564 | ||||
Underlying profit attributable to equity holders of AB InBev | 2 762 | 3 320 | ||||
| ||||||
Earnings per share (USD) | 0.98 | 1.28 | ||||
Underlying earnings per share (USD) | 1.37 | 1.66 |
| |||
Figure 2. Volumes (thousand hls) | ||||||||||||
2Q23 | Scope | Organic | 2Q24 | Organic growth | ||||||||
growth | Total | Own beer | ||||||||||
North America | 23 542 | -156 | - 747 | 22 639 | -3.2% | -3.9% | ||||||
Middle Americas | 37 893 | -4 | 493 | 38 381 | 1.3% | 1.8% | ||||||
South America | 35 737 | - | 232 | 35 969 | 0.6% | -0.9% | ||||||
EMEA | 22 884 | - | 968 | 23 852 | 4.2% | 3.8% | ||||||
Asia Pacific | 27 475 | - | -2 076 | 25 399 | -7.6% | -7.6% | ||||||
Global Export and Holding Companies | 51 | - | 11 | 62 | 21.2% | - | ||||||
AB InBev Worldwide | 147 583 | - 161 | -1 121 | 146 302 | -0.8% | -1.3% | ||||||
HY23 | Scope | Organic | HY24 | Organic growth | ||||||||
growth | Total | Own beer | ||||||||||
North America | 47 395 | -311 | -3 092 | 43 992 | -6.6% | -7.5% | ||||||
Middle Americas | 72 164 | -9 | 1 916 | 74 072 | 2.7% | 3.0% | ||||||
South America | 76 023 | - | 292 | 76 315 | 0.4% | -0.8% | ||||||
EMEA | 42 842 | - | 2 040 | 44 882 | 4.8% | 4.3% | ||||||
Asia Pacific | 49 589 | - | -3 145 | 46 444 | -6.3% | -6.3% | ||||||
Global Export and Holding Companies | 117 | - | 15 | 132 | 12.5% | - | ||||||
AB InBev Worldwide | 288 131 | - 320 | -1 973 | 285 837 | -0.7% | -1.3% | ||||||
Key Market Performances
United States: Improved market share trend, ongoing premiumization and productivity initiatives deliver double-digit bottom-line growth
Mexico: Mid-single digit top-line and double-digit bottom-line growth with margin expansion
Colombia: Record high volumes delivered double-digit top- and bottom-line growth with margin expansion
Brazil: Record high volumes delivered high-single digit top-line and double-digit bottom-line growth with margin expansion
Europe: High-single digit bottom-line growth with margin recovery
South Africa: Record high volumes delivered double digit top- and bottom-line growth with margin expansion
China: Revenue declined by double-digits, impacted by soft industry
Highlights from our other markets
Consolidated Income Statement
Figure 3. Consolidated income statement (million USD) | ||||||
2Q23 | 2Q24 | Organic | ||||
growth | ||||||
Revenue | 15 120 | 15 333 | 2.7% | |||
Cost of sales | -7 019 | -6 766 | 2.2% | |||
Gross profit | 8 101 | 8 567 | 7.0% | |||
SG&A | -4 707 | -4 813 | -2.3% | |||
Other operating income/(expenses) | 175 | 151 | -20.8% | |||
Normalized profit from operations (normalized EBIT) | 3 569 | 3 905 | 11.9% | |||
Non-underlying items above EBIT (incl. impairment losses) | -60 | -90 | ||||
Net finance income/(cost) | -1 283 | -1 170 | ||||
Non-underlying net finance income/(cost) | -1 078 | - 221 | ||||
Share of results of associates | 55 | 79 | ||||
Income tax expense | -595 | -752 | ||||
Profit | 607 | 1 751 | ||||
Profit attributable to non-controlling interest | 269 | 279 | ||||
Profit attributable to equity holders of AB InBev | 339 | 1 472 | ||||
| ||||||
Normalized EBITDA | 4 909 | 5 302 | 10.2% | |||
Underlying profit attributable to equity holders of AB InBev | 1 452 | 1 811 | ||||
. | ||||||
HY23 | HY24 | Organic | ||||
growth | ||||||
Revenue | 29 333 | 29 880 | 2.7% | |||
Cost of sales | -13 536 | -13 419 | -0.1% | |||
Gross profit | 15 796 | 16 461 | 4.9% | |||
SG&A | -9 051 | -9 248 | -1.9% | |||
Other operating income/(expenses) | 327 | 334 | -2.7% | |||
Normalized profit from operations (normalized EBIT) | 7 072 | 7 547 | 8.5% | |||
Non-underlying items above EBIT (incl. impairment losses) | -107 | -119 | ||||
Net finance income/(cost) | -2 520 | -2 357 | ||||
Non-underlying net finance income/(cost) | -703 | -530 | ||||
Share of results of associates | 105 | 137 | ||||
Non-underlying share of results of associates | - | 104 | ||||
Income tax expense | -1 192 | -1 546 | ||||
Profit | 2 655 | 3 236 | ||||
Profit attributable to non-controlling interest | 678 | 672 | ||||
Profit attributable to equity holders of AB InBev | 1 977 | 2 564 | ||||
| ||||||
Normalized EBITDA | 9 668 | 10 288 | 7.8% | |||
Underlying profit attributable to equity holders of AB InBev | 2 762 | 3 320 | ||||
. |
|
Non-underlying items above EBIT & Non-underlying share of results of associates
Figure 4. Non-underlying items above EBIT & Non-underlying share of results of associates (million USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Restructuring | -22 | -28 | -50 | -59 | ||||
Business and asset disposal (incl. impairment losses) | -19 | -62 | -38 | -60 | ||||
Claims and legal costs | -19 | - | -19 | - | ||||
Non-underlying items in EBIT | -60 | -90 | -107 | -119 | ||||
Non-underlying share of results of associates | - | - | - | 104 | ||||
Non-underlying share of results from associates of HY24 includes the impact from our associate Anadolu Efes’ adoption of IAS 29 hyperinflation accounting on their 2023 results.
Net finance income/(cost)
Figure 5. Net finance income/(cost) (million USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Net interest expense | -824 | -746 | -1 630 | -1 460 | ||||
Net interest on net defined benefit liabilities | -21 | -23 | -42 | -45 | ||||
Accretion expense | -202 | -191 | -385 | -382 | ||||
Net interest income on Brazilian tax credits | 47 | 25 | 78 | 61 | ||||
Other financial results | -283 | -235 | -540 | -530 | ||||
Net finance income/(cost) | -1 283 | -1 170 | -2 520 | -2 357 | ||||
Non-underlying net finance income/(cost)
Figure 6. Non-underlying net finance income/(cost) (million USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Mark-to-market | -1 078 | -264 | -703 | -507 | ||||
Gain/(loss) on bond redemption and other | - | 43 | - | -23 | ||||
Non-underlying net finance income/(cost) | -1 078 | -221 | -703 | -530 | ||||
Non-underlying net finance cost in HY24 includes mark-to-market losses on derivative instruments entered into in order to hedge our share-based payment programs and shares issued in relation to the combination with Grupo Modelo and SAB, and a 43 million USD gain related to the completion of tender offers of notes issued by the company and certain of its subsidiaries.
The number of shares covered by the hedging of our share-based payment program, the deferred share instrument and the restricted shares are shown in figure 7, together with the opening and closing share prices.
Figure 7. Non-underlying equity derivative instruments | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Share price at the start of the period (Euro) | 61.33 | 56.46 | 56.27 | 58.42 | ||||
Share price at the end of the period (Euro) | 51.83 | 54.12 | 51.83 | 54.12 | ||||
Number of equity derivative instruments at the end of the period (millions) | 100.5 | 100.5 | 100.5 | 100.5 | ||||
Income tax expense
Figure 8. Income tax expense (million USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Income tax expense | 595 | 752 | 1 192 | 1 546 | ||||
Effective tax rate | 51.9% | 31.0% | 31.9% | 34.1% | ||||
Normalized effective tax rate | 27.8% | 27.4% | 27.3% | 27.2% | ||||
The 2Q23 and 2Q24 effective tax rates were negatively impacted by non-deductible losses from derivatives related to the hedging of share-based payment programs and of the shares issued in a transaction related to the combination with Grupo Modelo and SAB.
Furthermore, the HY24 effective tax rate includes 133 million USD of non-underlying tax expenses, reflecting mainly the impact of a 240 million USD (4.5 billion ZAR) non-underlying tax cost following the resolution of the South African tax matters as described in note 21 Contingencies of the HY24 Unaudited Interim Report and the release of tax provisions.
Figure 9. Underlying Profit attributable to equity holders of AB InBev (million USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Profit attributable to equity holders of AB InBev | 339 | 1 472 | 1 977 | 2 564 | ||||
Net impact of non-underlying items on profit | 1 092 | 313 | 750 | 675 | ||||
Hyperinflation impacts in underlying profit | 22 | 26 | 35 | 81 | ||||
Underlying profit attributable to equity holders of AB InBev | 1 452 | 1 811 | 2 762 | 3 320 | ||||
Basic and underlying EPS
Figure 10. Earnings per share (USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Basic EPS | 0.17 | 0.73 | 0.98 | 1.28 | ||||
Net impact of non-underlying items on profit | 0.53 | 0.16 | 0.36 | 0.34 | ||||
Hyperinflation impacts in EPS | 0.01 | 0.01 | 0.02 | 0.04 | ||||
Underlying EPS | 0.72 | 0.90 | 1.37 | 1.66 | ||||
Weighted average number of ordinary and restricted shares (million) | 2 016 | 2 005 | 2 016 | 2 005 | ||||
Figure 11. Key components - Underlying EPS in USD | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Normalized EBIT before hyperinflation | 1.78 | 1.96 | 3.54 | 3.78 | ||||
Hyperinflation impacts in normalized EBIT | -0.01 | -0.01 | -0.03 | -0.02 | ||||
Normalized EBIT | 1.77 | 1.95 | 3.51 | 3.76 | ||||
Net finance cost | -0.64 | -0.58 | -1.25 | -1.18 | ||||
Income tax expense | -0.31 | -0.37 | -0.62 | -0.70 | ||||
Associates & non-controlling interest | -0.11 | -0.10 | -0.29 | -0.27 | ||||
Hyperinflation impacts in EPS | 0.01 | 0.01 | 0.02 | 0.04 | ||||
Underlying EPS | 0.72 | 0.90 | 1.37 | 1.66 | ||||
Weighted average number of ordinary and restricted shares (million) | 2 016 | 2 005 | 2 016 | 2 005 | ||||
Reconciliation between normalized EBITDA and profit attributable to equity holders
Figure 12. Reconciliation of normalized EBITDA to profit attributable to equity holders of AB InBev (million USD) | ||||||||
2Q23 | 2Q24 | HY23 | HY24 | |||||
Profit attributable to equity holders of AB InBev | 339 | 1 472 | 1 977 | 2 564 | ||||
Non-controlling interests | 269 | 279 | 678 | 672 | ||||
Profit | 607 | 1 751 | 2 655 | 3 236 | ||||
Income tax expense | 595 | 752 | 1 192 | 1 546 | ||||
Share of result of associates | -55 | -79 | -105 | -137 | ||||
Non-underlying share of results of associates | - | - | - | - 104 | ||||
Net finance (income)/cost | 1 283 | 1 170 | 2 520 | 2 357 | ||||
Non-underlying net finance (income)/cost | 1 078 | 221 | 703 | 530 | ||||
Non-underlying items above EBIT (incl. impairment losses) | 60 | 90 | 107 | 119 | ||||
Normalized EBIT | 3 569 | 3 905 | 7 072 | 7 547 | ||||
Depreciation, amortization and impairment | 1 340 | 1 397 | 2 596 | 2 741 | ||||
Normalized EBITDA | 4 909 | 5 302 | 9 668 | 10 288 | ||||
Normalized EBITDA and normalized EBIT are measures utilized by AB InBev to demonstrate the company’s underlying performance.
Normalized EBITDA is calculated excluding the following effects from profit attributable to equity holders of AB InBev: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) non-underlying share of results of associates; (v) net finance income or cost; (vi) non-underlying net finance income or cost; (vii) non-underlying items above EBIT; and (viii) depreciation, amortization and impairment.
Normalized EBITDA and normalized EBIT are not accounting measures under IFRS and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Normalized EBITDA and normalized EBIT do not have a standard calculation method and AB InBev’s definition of normalized EBITDA and normalized EBIT may not be comparable to that of other companies.
Financial position
Figure 13. Cash Flow Statement (million USD) | ||||
HY23 | HY24 | |||
Operating activities | ||||
Profit of the period | 2 655 | 3 236 | ||
Interest, taxes and non-cash items included in profit | 7 512 | 7 588 | ||
Cash flow from operating activities before changes in working capital and use of provisions | 10 167 | 10 824 | ||
| ||||
Change in working capital | -4 615 | -4 170 | ||
Pension contributions and use of provisions | - 192 | - 251 | ||
Interest and taxes (paid)/received | -3 806 | -3 958 | ||
Dividends received | 43 | 123 | ||
Cash flow from/(used in) operating activities | 1 597 | 2 568 | ||
| ||||
Investing activities | ||||
Net capex | -2 063 | -1 684 | ||
Sale/(acquisition) of subsidiaries, net of cash disposed/ acquired of | - 8 | - 19 | ||
Net proceeds from sale/(acquisition) of other assets | - 18 | - 29 | ||
Cash flow from/(used in) investing activities | -2 089 | -1 732 | ||
| ||||
Financing activities | ||||
Net (repayments of) / proceeds from borrowings | 155 | 1 124 | ||
Dividends paid | -1 923 | -2 142 | ||
Share buyback | - | - 838 | ||
Payment of lease liabilities | - 359 | - 406 | ||
Derivative financial instruments | - 360 | - 172 | ||
Sale/(acquisition) of non-controlling interests | - 3 | - 414 | ||
Other financing cash flows | - 304 | - 465 | ||
Cash flow from/(used in) financing activities | -2 795 | -3 313 | ||
. | ||||
Net increase/(decrease) in cash and cash equivalents | -3 287 | -2 476 | ||
HY24 recorded a decrease in cash and cash equivalents of 2 476 million USD compared to a decrease of 3 287 million USD in HY23, with the following movements:
Our net debt increased to 70.4 billion USD as of 30 June 2024 from 67.6 billion USD as of 31 December 2023.
Our net debt to normalized EBITDA ratio was 3.42x as of 30 June 2024. Our optimal capital structure is a net debt to normalized EBITDA ratio of around 2x.
We continue to proactively manage our debt portfolio. 99% of our bond portfolio holds a fixed-interest rate, 43% is denominated in currencies other than USD and maturities are well-distributed across the next several years.
As of 30 June 2024, we had total liquidity of 17.7 billion USD, which consisted of 10.1 billion USD available under committed long-term credit facilities and 7.6 billion USD of cash, cash equivalents and short-term investments in debt securities less bank overdrafts.
Notes
To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. For FY24, the definition of organic revenue growth has been amended to cap the price growth in Argentina to a maximum of 2% per month (26.8% year-over-year). Corresponding adjustments are made to all income statement related items in the organic growth calculations through scope changes. Scope changes also represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. The organic growth of our global brands, Budweiser, Stella Artois, Corona and Michelob Ultra, excludes exports to Australia for which a perpetual license was granted to a third party upon disposal of the Australia operations in 2020. All references per hectoliter (per hl) exclude US non-beer activities. Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a “normalized” basis, which means they are presented before non-underlying items. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the Company’s performance. We are reporting the results from Argentina applying hyperinflation accounting since 3Q18. The IFRS rules (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. In HY24, we reported a negative impact from hyperinflation accounting on the profit attributable to equity holders of AB InBev of 81 million USD. The impact in HY24 Basic EPS was -0.04 USD. Values in the figures and annexes may not add up, due to rounding. 2Q24 and HY24 EPS is based upon a weighted average of 2 005 million shares compared to a weighted average of 2 016 million shares for 2Q23 and HY23.
Legal disclaimer
This release contains “forward-looking statements”. These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “estimates”, “likely”, “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including, but not limited to the risks and uncertainties relating to AB InBev that are described under Item 3.D of AB InBev’s Annual Report on Form 20-F filed with the SEC on 11 March 2024. Many of these risks and uncertainties are, and will be, exacerbated by any further worsening of the global business and economic environment, including as a result of the ongoing conflict in Russia and Ukraine and in the Middle East, including the conflict in the Red Sea. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The second quarter 2024 (2Q24) and half year 2024 (HY24) financial data set out in Figure 1 (except for the volume information), Figures 3 to 5, 6, 8, 9, 12 and 13 of this press release have been extracted from the group’s unaudited condensed consolidated interim financial statements as of and for the six months ended 30 June 2024, which have been reviewed by our statutory auditors PwC Réviseurs d’Entreprises SRL / PwC Bedrijfsrevisoren BV in accordance with the standards of the Public Company Accounting Oversight Board (United States). Financial data included in Figures 7, 10, 11 and 14 have been extracted from the underlying accounting records as of and for the six months ended 30 June 2024 (except for the volume information). References in this document to materials on our websites, such as www.ab-inbev.com, are included as an aid to their location and are not incorporated by reference into this document.
Conference call and webcast
Investor Conference call and webcast on Thursday, 1 August 2024:
1.00pm Brussels / 12.00pm London / 7.00am New York
Registration details:
Webcast (listen-only mode):
AB InBev 2Q24 Results Webcast
To join by phone, please use one of the following two phone numbers:
Toll-Free: +1-877-407-8029
Toll: +1-201-689-8029
About AB InBev
Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 155,000 colleagues based in nearly 50 countries worldwide. For 2023, AB InBev’s reported revenue was 59.4 billion USD (excluding JVs and associates).
Annex 1: Segment reporting (2Q)
AB InBev Worldwide | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 147 583 | -161 | - | -1 121 | 146 302 | -0.8% | ||||||
of which AB InBev own beer | 128 750 | -155 | - | -1 669 | 126 926 | -1.3% | ||||||
Revenue | 15 120 | 422 | -622 | 413 | 15 333 | 2.7% | ||||||
Cost of sales | -7 019 | -395 | 493 | 155 | -6 766 | 2.2% | ||||||
Gross profit | 8 101 | 27 | -128 | 568 | 8 567 | 7.0% | ||||||
SG&A | -4 707 | -283 | 286 | -108 | -4 813 | -2.3% | ||||||
Other operating income/(expenses) | 175 | 12 | 2 | -38 | 151 | -20.8% | ||||||
Normalized EBIT | 3 569 | -244 | 159 | 421 | 3 905 | 11.9% | ||||||
Normalized EBITDA | 4 909 | -173 | 67 | 499 | 5 302 | 10.2% | ||||||
Normalized EBITDA margin | 32.5% | 34.6% | 236bps | |||||||||
| ||||||||||||
North America | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 23 542 | -156 | - | -747 | 22 639 | -3.2% | ||||||
Revenue | 3 953 | -38 | -1 | -51 | 3 864 | -1.3% | ||||||
Cost of sales | -1 745 | 22 | - | 117 | -1 606 | 6.8% | ||||||
Gross profit | 2 208 | -16 | - | 66 | 2 258 | 3.0% | ||||||
SG&A | -1 215 | 4 | - | 110 | -1 101 | 9.1% | ||||||
Other operating income/(expenses) | 10 | - | - | -6 | 4 | - | ||||||
Normalized EBIT | 1 003 | -12 | - | 169 | 1 161 | 17.1% | ||||||
Normalized EBITDA | 1 189 | -13 | - | 162 | 1 338 | 13.8% | ||||||
Normalized EBITDA margin | 30.1% | 34.6% | 458bps | |||||||||
| ||||||||||||
Middle Americas | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 37 893 | -4 | - | 493 | 38 381 | 1.3% | ||||||
Revenue | 4 084 | -7 | 205 | 240 | 4 522 | 5.9% | ||||||
Cost of sales | -1 571 | -6 | -67 | 51 | -1 593 | 3.2% | ||||||
Gross profit | 2 513 | -13 | 138 | 292 | 2 929 | 11.7% | ||||||
SG&A | -985 | - | -51 | -64 | -1 100 | -6.5% | ||||||
Other operating income/(expenses) | 10 | 6 | 1 | -5 | 11 | - | ||||||
Normalized EBIT | 1 538 | -8 | 88 | 223 | 1 841 | 14.5% | ||||||
Normalized EBITDA | 1 916 | -7 | 104 | 206 | 2 219 | 10.8% | ||||||
Normalized EBITDA margin | 46.9% | 49.1% | 215bps | |||||||||
| ||||||||||||
South America | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 35 737 | - | - | 232 | 35 969 | 0.6% | ||||||
Revenue | 2 742 | 463 | -588 | 168 | 2 785 | 6.1% | ||||||
Cost of sales | -1 423 | -401 | 424 | -27 | -1 427 | -1.9% | ||||||
Gross profit | 1 319 | 63 | -164 | 141 | 1 359 | 10.5% | ||||||
SG&A | -926 | -311 | 285 | -24 | -976 | -2.4% | ||||||
Other operating income/(expenses) | 81 | 4 | -5 | 19 | 99 | 22.7% | ||||||
Normalized EBIT | 475 | -244 | 115 | 136 | 482 | 30.2% | ||||||
Normalized EBITDA | 737 | -172 | 31 | 154 | 750 | 21.7% | ||||||
Normalized EBITDA margin | 26.9% | 26.9% | 380bps |
EMEA | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 22 884 | - | - | 968 | 23 852 | 4.2% | ||||||
Revenue | 2 248 | 5 | -177 | 226 | 2 301 | 10.0% | ||||||
Cost of sales | -1 207 | -4 | 122 | -89 | -1 179 | -7.4% | ||||||
Gross profit | 1 041 | - | -56 | 137 | 1 122 | 13.1% | ||||||
SG&A | -662 | -6 | 34 | -57 | -691 | -8.6% | ||||||
Other operating income/(expenses) | 47 | 1 | - | -14 | 34 | -28.3% | ||||||
Normalized EBIT | 426 | -5 | -22 | 66 | 465 | 15.6% | ||||||
Normalized EBITDA | 680 | -5 | -40 | 86 | 721 | 12.7% | ||||||
Normalized EBITDA margin | 30.3% | 31.3% | 73bps | |||||||||
| ||||||||||||
Asia Pacific | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 27 475 | - | - | -2 076 | 25 399 | -7.6% | ||||||
Revenue | 1 973 | -1 | -61 | -163 | 1 749 | -8.2% | ||||||
Cost of sales | -927 | -6 | 27 | 85 | -821 | 9.1% | ||||||
Gross profit | 1 046 | -7 | -33 | -77 | 928 | -7.4% | ||||||
SG&A | -584 | -8 | 18 | 24 | -549 | 4.1% | ||||||
Other operating income/(expenses) | 21 | 1 | -1 | 10 | 30 | 44.7% | ||||||
Normalized EBIT | 483 | -14 | -16 | -43 | 410 | -9.2% | ||||||
Normalized EBITDA | 645 | -15 | -22 | -38 | 570 | -6.0% | ||||||
Normalized EBITDA margin | 32.7% | 32.6% | 78bps | |||||||||
| ||||||||||||
Global Export and Holding Companies | 2Q23 | Scope | Currency Translation | Organic Growth | 2Q24 | Organic Growth | ||||||
Total volumes (thousand hls) | 51 | - | - | 11 | 62 | 21.2% | ||||||
Revenue | 119 | - | - | -8 | 112 | -6.4% | ||||||
Cost of sales | -147 | - | -13 | 18 | -141 | 12.1% | ||||||
Gross profit | -27 | - | -12 | 10 | -30 | 37.2% | ||||||
SG&A | -336 | 38 | -1 | -97 | -396 | -32.7% | ||||||
Other operating income/(expenses) | 7 | - | 7 | -42 | -28 | - | ||||||
Normalized EBIT | -357 | 38 | -6 | -129 | -453 | -40.4% | ||||||
Normalized EBITDA | -257 | 38 | -6 | -70 | -295 | -32.1% | ||||||
Annex 2: Segment reporting (HY)
AB InBev Worldwide | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 288 131 | - 320 | - | -1 973 | 285 837 | -0.7% | ||||||
of which AB InBev own beer | 249 810 | - 304 | - | -3 192 | 246 313 | -1.3% | ||||||
Revenue | 29 333 | 1 732 | -1 970 | 785 | 29 880 | 2.7% | ||||||
Cost of sales | -13 536 | -1 019 | 1 148 | - 11 | -13 419 | -0.1% | ||||||
Gross profit | 15 796 | 712 | - 822 | 774 | 16 461 | 4.9% | ||||||
SG&A | -9 051 | - 672 | 646 | - 171 | -9 248 | -1.9% | ||||||
Other operating income/(expenses) | 327 | 11 | 5 | -9 | 334 | -2.7% | ||||||
Normalized EBIT | 7 072 | 51 | - 170 | 594 | 7 547 | 8.5% | ||||||
Normalized EBITDA | 9 668 | 218 | - 352 | 755 | 10 288 | 7.8% | ||||||
Normalized EBITDA margin | 33.0% | 34.4% | 165bps | |||||||||
| ||||||||||||
North America | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 47 395 | - 311 | - | -3 092 | 43 992 | -6.6% | ||||||
Revenue | 7 926 | - 75 | 1 | - 396 | 7 457 | -5.0% | ||||||
Cost of sales | -3 420 | 42 | - 1 | 228 | -3 150 | 6.7% | ||||||
Gross profit | 4 506 | - 32 | 1 | - 169 | 4 307 | -3.8% | ||||||
SG&A | -2 354 | 21 | - 1 | 147 | -2 186 | 6.3% | ||||||
Other operating income/(expenses) | 18 | - | - | -26 | -8 | - | ||||||
Normalized EBIT | 2 171 | - 11 | - | - 48 | 2 112 | -2.2% | ||||||
Normalized EBITDA | 2 539 | - 13 | - | - 62 | 2 464 | -2.5% | ||||||
Normalized EBITDA margin | 32.0% | 33.0% | 88bps | |||||||||
Middle Americas | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 72 164 | - 9 | - | 1 916 | 74 072 | 2.7% | ||||||
Revenue | 7 573 | - 12 | 494 | 519 | 8 574 | 6.9% | ||||||
Cost of sales | -2 926 | - 13 | - 182 | - 58 | -3 179 | -2.0% | ||||||
Gross profit | 4 646 | - 24 | 312 | 461 | 5 395 | 10.0% | ||||||
SG&A | -1 863 | 4 | - 122 | - 84 | -2 065 | -4.5% | ||||||
Other operating income/(expenses) | 8 | 13 | 2 | - | 23 | - | ||||||
Normalized EBIT | 2 792 | - 8 | 192 | 377 | 3 353 | 13.5% | ||||||
Normalized EBITDA | 3 494 | - | 237 | 374 | 4 105 | 10.7% | ||||||
Normalized EBITDA margin | 46.1% | 47.9% | 166bps | |||||||||
| ||||||||||||
South America | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 76 023 | - | - | 292 | 76 315 | 0.4% | ||||||
Revenue | 5 849 | 1 813 | -1 971 | 327 | 6 018 | 5.6% | ||||||
Cost of sales | -2 949 | -1 031 | 1 026 | - 59 | -3 013 | -2.0% | ||||||
Gross profit | 2 900 | 782 | - 944 | 267 | 3 005 | 9.1% | ||||||
SG&A | -1 804 | - 721 | 663 | - 55 | -1 917 | -2.9% | ||||||
Other operating income/(expenses) | 171 | -5 | 9 | 40 | 215 | 23.1% | ||||||
Normalized EBIT | 1 268 | 57 | - 273 | 252 | 1 304 | 20.5% | ||||||
Normalized EBITDA | 1 766 | 220 | - 449 | 298 | 1 834 | 17.3% | ||||||
Normalized EBITDA margin | 30.2% | 30.5% | 326bps |
EMEA | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 42 842 | - | - | 2 040 | 44 882 | 4.8% | ||||||
Revenue | 4 070 | 6 | - 372 | 524 | 4 228 | 12.8% | ||||||
Cost of sales | -2 210 | - 6 | 249 | - 247 | -2 215 | -11.2% | ||||||
Gross profit | 1 860 | 1 | - 123 | 276 | 2 014 | 14.9% | ||||||
SG&A | -1 307 | - 7 | 70 | - 61 | -1 305 | -4.7% | ||||||
Other operating income/(expenses) | 83 | 1 | -3 | -2 | 79 | -2.6% | ||||||
Normalized EBIT | 635 | -5 | -56 | 213 | 787 | 33.8% | ||||||
Normalized EBITDA | 1 142 | - 5 | - 95 | 248 | 1 290 | 21.8% | ||||||
Normalized EBITDA margin | 28.1% | 30.5% | 221bps | |||||||||
| ||||||||||||
Asia Pacific | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 49 589 | - | - | -3 145 | 46 444 | -6.3% | ||||||
Revenue | 3 679 | -1 | -123 | -171 | 3 383 | -4.6% | ||||||
Cost of sales | -1 750 | -13 | 55 | 124 | -1 583 | 7.0% | ||||||
Gross profit | 1 929 | -14 | -68 | -47 | 1 800 | -2.5% | ||||||
SG&A | -1 033 | -8 | 35 | 12 | -994 | 1.2% | ||||||
Other operating income/(expenses) | 53 | 1 | -2 | 4 | 56 | 8.0% | ||||||
Normalized EBIT | 949 | -21 | -36 | -31 | 861 | -3.3% | ||||||
Normalized EBITDA | 1 273 | -22 | -47 | -17 | 1 186 | -1.4% | ||||||
Normalized EBITDA margin | 34.6% | 35.0% | 116bps | |||||||||
| ||||||||||||
Global Export and Holding Companies | HY23 | Scope | Currency Translation | Organic Growth | HY24 | Organic Growth | ||||||
Total volumes (thousand hls) | 117 | - | - | 15 | 132 | 12.5% | ||||||
Revenue | 236 | - | 1 | -16 | 221 | -6.9% | ||||||
Cost of sales | -281 | - | - | 2 | -279 | 0.7% | ||||||
Gross profit | -45 | - | 1 | -14 | -59 | - | ||||||
SG&A | -692 | 38 | 2 | -129 | -781 | -19.7% | ||||||
Other operating income/(expenses) | -6 | - | - | -25 | -31 | - | ||||||
Normalized EBIT | -742 | 38 | 2 | -168 | -870 | -23.9% | ||||||
Normalized EBITDA | -545 | 38 | 3 | -86 | -590 | -16.9% | ||||||
Annex 3: Consolidated statement of financial position
Million US dollar | 30 June 2024 | 31 December 2023 | ||
ASSETS | ||||
Non-current assets | ||||
Property, plant and equipment | 25 086 | 26 818 | ||
Goodwill | 113 451 | 117 043 | ||
Intangible assets | 40 703 | 41 286 | ||
Investments in associates | 4 865 | 4 872 | ||
Investment securities | 185 | 178 | ||
Deferred tax assets | 2 771 | 2 935 | ||
Pensions and similar obligations | 12 | 12 | ||
Income tax receivables | 749 | 844 | ||
Derivatives | 184 | 44 | ||
Trade and other receivables | 1 687 | 1 941 | ||
Total non-current assets | 189 694 | 195 973 | ||
| ||||
Current assets | ||||
Investment securities | 252 | 67 | ||
Inventories | 5 567 | 5 583 | ||
Income tax receivables | 611 | 822 | ||
Derivatives | 448 | 505 | ||
Trade and other receivables | 6 705 | 6 024 | ||
Cash and cash equivalents | 7 392 | 10 332 | ||
Assets classified as held for sale | 51 | 34 | ||
Total current assets | 21 026 | 23 367 | ||
| ||||
Total assets | 210 720 | 219 340 | ||
| ||||
EQUITY AND LIABILITIES | ||||
Equity | ||||
Issued capital | 1 736 | 1 736 | ||
Share premium | 17 620 | 17 620 | ||
Reserves | 15 617 | 20 276 | ||
Retained earnings | 43 543 | 42 215 | ||
Equity attributable to equity holders of AB InBev | 78 517 | 81 848 | ||
| ||||
Non-controlling interests | 10 725 | 10 828 | ||
Total equity | 89 241 | 92 676 | ||
| ||||
Non-current liabilities | ||||
Interest-bearing loans and borrowings | 75 944 | 74 163 | ||
Pensions and similar obligations | 1 495 | 1 673 | ||
Deferred tax liabilities | 11 761 | 11 874 | ||
Income tax payables | 408 | 589 | ||
Derivatives | 55 | 151 | ||
Trade and other payables | 880 | 738 | ||
Provisions | 368 | 320 | ||
Total non-current liabilities | 90 912 | 89 508 | ||
| ||||
Current liabilities | ||||
Bank overdrafts | 17 | 17 | ||
Interest-bearing loans and borrowings | 2 240 | 3 987 | ||
Income tax payables | 1 144 | 1 583 | ||
Derivatives | 5 223 | 5 318 | ||
Trade and other payables | 21 708 | 25 981 | ||
Provisions | 235 | 269 | ||
Total current liabilities | 30 566 | 37 156 | ||
| ||||
Total equity and liabilities | 210 720 | 219 340 | ||
Annex 4: Consolidated statement of cash flows
For the six-month period ended 30 June | ||||
Million US dollar | 2024 | 2023 | ||
. | ||||
OPERATING ACTIVITIES | ||||
Profit of the period | 3 236 | 2 655 | ||
Depreciation, amortization and impairment | 2 741 | 2 595 | ||
Net finance cost/(income) | 2 887 | 3 223 | ||
Equity-settled share-based payment expense | 315 | 286 | ||
Income tax expense | 1 546 | 1 192 | ||
Other non-cash items | 339 | 321 | ||
Share of result of associates | -241 | -105 | ||
Cash flow from operating activities before changes in working capital and use of provisions | 10 824 | 10 167 | ||
Decrease/(increase) in trade and other receivables | -1 154 | -1 325 | ||
Decrease/(increase) in inventories | -325 | -228 | ||
Increase/(decrease) in trade and other payables | -2 691 | -3 062 | ||
Pension contributions and use of provisions | -251 | -192 | ||
Cash generated from operations | 6 403 | 5 360 | ||
Interest paid | -2 001 | -2 322 | ||
Interest received | 303 | 512 | ||
Dividends received | 123 | 43 | ||
Income tax paid | -2 260 | -1 996 | ||
Cash flow from/(used in) operating activities | 2 568 | 1 597 | ||
. | ||||
INVESTING ACTIVITIES | ||||
Acquisition of property, plant and equipment and of intangible assets | -1 735 | -2 107 | ||
Proceeds from sale of property, plant and equipment and of intangible assets | 52 | 44 | ||
Sale/(acquisition) of subsidiaries, net of cash disposed/ acquired of | -19 | -8 | ||
Proceeds from sale/(acquisition) of other assets | -29 | -18 | ||
Cash flow from/(used in) investing activities | -1 732 | -2 089 | ||
. | ||||
FINANCING ACTIVITIES | ||||
Proceeds from borrowings | 5 466 | 181 | ||
Repayments of borrowings | -4 342 | -26 | ||
Dividends paid | -2 142 | -1 923 | ||
Share buyback | -838 | - | ||
Payment of lease liabilities | -406 | -359 | ||
Derivative financial instruments | -172 | -360 | ||
Sale/(acquisition) of non-controlling interests | -414 | -3 | ||
Other financing cash flows | -465 | -305 | ||
Cash flow from/(used in) financing activities | -3 313 | -2 795 | ||
. | ||||
Net increase/(decrease) in cash and cash equivalents | -2 476 | -3 287 | ||
Cash and cash equivalents less bank overdrafts at beginning of year | 10 314 | 9 890 | ||
Effect of exchange rate fluctuations | -463 | 191 | ||
Cash and cash equivalents less bank overdrafts at end of period | 7 375 | 6 794 |
Investors
Shaun Fullalove
E-mail: shaun.fullalove@ab-inbev.com
Ekaterina Baillie
E-mail: ekaterina.baillie@ab-inbev.com
Cyrus Nentin
E-mail: cyrus.nentin@ab-inbev.com
Media
Media Relations
E-mail: media.relations@ab-inbev.com
AB InBev Strategic Priorities (Graphic: Business Wire)